Status:
COMPLETED
CavatermTM for Idiopathic Functional Menometrorraghia
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Cavaterm™ System
Eligibility:
FEMALE
18+ years
Brief Summary
The prevalence of menometrorrhagia is estimated at 11% to 13% in the general population and increases with age to reach 24% in 36-40 year olds. It is the leading cause of gynecological consultations. ...
Eligibility Criteria
Inclusion
- Inclusion Criteria \* :
- women over 18
- patient who benefited from treatment with the Cavaterm™ system for idiopathic functional menometrorrhagia
- treatment between January 2024 and December 2024
- person having expressed his non-opposition
- Exclusion Criteria \* :
- inability to understand the information given
- person deprived of liberty
- person under guardianship
Exclusion
Key Trial Info
Start Date :
June 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT07205146
Start Date
June 1 2025
End Date
August 1 2025
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Femme Mère Enfant
Lyon, France, 69500